Asia Pacific: The Vaginitis Therapeutics market in Asia Pacific is anticipated to experience rapid growth, attributed to the increasing awareness about women's health and rising disposable income in countries like China, Japan, and South Korea. The growing demand for innovative treatment options and the presence of key market players are also driving market growth in the region.
Europe: The Vaginitis Therapeutics market in Europe is likely to register steady growth, supported by the growing geriatric population and the increasing incidences of vaginitis in countries such as the United Kingdom, Germany, and France. The strong presence of healthcare facilities and the high healthcare expenditure are also contributing to market expansion in the region.